NV
Publications
29
Views
13,668
Downloads
8,799
Supervised works
0
1 - 29 of 29
Title Published in Access level OA Policy Year Views Downloads
QT prolongation alerts lead to monitoring but rarely to therapeutic changes : a prospective hospital studyFrontiers in pharmacology
accessLevelPublic
2026 6 12
Sepsis outbreak following a probable extrinsic contamination of propofol by Escherichia coli, Geneva, 2024Antimicrobial resistance and infection control
accessLevelPublic
2025 8 51
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitalsLancet. Infectious diseases
accessLevelPublic
2022 238 641
Bacteremia Detection in Second or Subsequent Blood Cultures Among Hospitalized Patients in a Tertiary Care HospitalJAMA network open
accessLevelPublic
2022 238 112
A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and VaccinationViruses
accessLevelPublic
2022 184 237
Vulnerable patients forgo health care during the first wave of the Covid-19 pandemicPreventive Medicine
accessLevelPublic
2021 234 133
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapyJHEP Reports : Innovation in Hepatology
accessLevelPublic
2021 305 191
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMedical mycology
accessLevelRestricted
2021 364 1
Development and validation of the OUTCoV score to predict the risk of hospitalisation among patients with SARS-CoV-2 infection in ambulatory settings: a prospective cohort studyBMJ Open
accessLevelPublic
2021 294 180
SARS-CoV-2 testing strategy: A comparison of restricted and extended strategies in a Swiss outpatient cohort from the community and hospital employeesPloS one
accessLevelPublic
2021 221 145
Determination of antiretroviral drugs for buyers' club in Switzerland using capillary electrophoresis methodsElectrophoresis
accessLevelRestricted
2020 292 2
The Swiss Cheese Prescribing Model for Precision MedicineAmerican Journal of Medicine
accessLevelPublic
2020 313 276
How to Develop and Implement a Computerized Decision Support System Integrated for Antimicrobial Stewardship? Experiences From Two Swiss Hospital SystemsFrontiers in digital health
accessLevelPublic
2020 188 203
Buyers' club : une alternative pour l'accès au traitement ?Revue médicale suisse
accessLevelPublic
2020 418 257
Impact of restricting procalcitonin measurements in a Swiss tertiary-care hospital on antibiotic use, clinical outcomes, and costs: An interrupted time-series analysisInfection Control and Hospital Epidemiology
accessLevelPublic
2020 286 94
Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costsSwiss Medical Weekly
accessLevelPublic
2020 511 474
Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionalsPLOS ONE
accessLevelPublic
2019 281 263
Life cycle of a drug – a perspective for policy makers
accessLevelRestricted
2018 745 12
A buyers' club to improve access to hepatitis C treatment for vulnerable populationsSwiss Medical Weekly
accessLevelPublic
2018 1,240 501
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineThe Pharmacogenomics Journal
accessLevelPublic
2018 663 387
Snapshot of the prescribing practice for the clopidogrel and esomeprazole coprescription and cost evaluation of the application guidelinesPharmacology research & perspectives
accessLevelPublic
2016 703 388
Early specialized care after a first unprovoked epileptic seizureJournal of neurology
accessLevelRestricted
2016 677 2
Drug Pricing Evolution in Hepatitis CPloS one
accessLevelPublic
2016 1,369 662
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysisThe Lancet. Psychiatry
accessLevelRestricted
2014 560 0
Effets indésirables des inhibiteurs de la pompe à proton: faut-il craindre de les prescrire au long cours ?La Revue de médecine interne
accessLevelPublic
2012 773 2,266
Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control studyClinical infectious diseases
accessLevelRestricted
2011 654 0
Politique du médicament : modéliser l'efficience dans une perspective hospitalière et sociétale au moyen des time series
accessLevelPublic
2011 512 1,309
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measuresInfection control and hospital epidemiology
accessLevelRestricted
2011 652 0
Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unitThe Journal of infection
accessLevelRestricted
2009 739 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack